Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30455
Study of Sickle Cell Syndromes in the Population of the Region of Batna

Authors: M. Yahia, S. Benbia, A. Zidani, H. Bousselsela, K .Belhadi

Abstract:

Sickle cell anemia is a recessive genetic disease caused by the presence in the red blood cell, of abnormal hemoglobin called hemoglobin S. It results from the replacement in the beta chain of the acid glutamic acid by valin at position 6. Topics may be homozygous (SS) or heterozygous (AS) most often asymptomatic. Other mutations result in compound heterozygous: - Synthesis of hemoglobin C mutation in the sixth leucin codon (heterozygous SC); - ß-thalassemia (heterozygous S-ß thalassemia). SS homozygous, heterozygous SC and S- ß -thalassemia are grouped under the major sickle cell syndromes. To make a laboratory diagnosis of hemoglobinopathies in a portion of the population in region of Batna, our study was conducted on 115 patients with suspected sickle cell anemia, all cases have benefited from hematological tests as blood count (count RBC, calculated erythrocyte indices, MCV and MCHC, measuring the hemoglobin concentration) and a biochemical test in this case electrophoresis CAPILLARYS HEMOGLOBIN (E). The results showed: 27 cases of sickle cell anemia were found on 115 suspected cases, 73,03% homozygous sickle cell disease and 59,25% sickle cell trait. Finally, the double heterozygous S/C, represent the incidence rate of 3, 70%.

Keywords: hemoglobin, laboratory diagnosis, sickle cell syndromes

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1080028

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1187

References:


[1] P. Basset, Y. Beuzard, M. C. Garel, and J. Rosa. " Isoelectric focusing of human hemoglobin: its application to screening, to the characterization of 70 variants, and to the Study of modified fractions of normal hemoglobin," Blood, , Vol. 51, pp. 971-82. 1978.
[2] M. H. Steinberg, "Management of sickle cell disease." N Engl J Med, vol. 340, pp. 1021-1030. 1999.
[3] J. Bardakjian-Michau, , J. L. Dhondt, , R. Ducrooq, F. Galactéros, A. Guyard, , F. X. Huchet , A. Lahary, D. Lena-Russo, P. Maboudou, ML. North, C. Prehu, AM. Soumm, M. Verschelde, and H. Wajcman, "Best practices study of hemoglobin," Ann. Bio. Clin, vol. 61 .pp 401-409. 2003.
[4] M. Vanbourdolle, " Biochemistry Hematology," pp. 6-1116 . 2007.
[5] E. Kafando, LBG. Savadogo, and J. Ayéroué, "Sickle cell syndromes in major: an anonymous survey of the medical profession in Burkina Faso," Med. Too,vol. 68.pp. 241-246.2008.
[6] D. Tosteson, E. Carlsen ,and E. Dunham " The effects of sickling is Lon transport," J Clin Invest, vol.31.pp. 406-411. 1952.
[7] THJ. Huisman, and JHP. Jonxis, "The Hemoglobinopathies: techniques of identification," pp. 456 .1977.
[8] Joutovsky, J. Hadzi-Nesic, and MA Nardi ,"HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60 000 samples in a clinical diagnostic laboratories," Cli. Chem,, vol. 50, 10 .pp. 1736-1747. 2004.
[9] F. Galacteros, "Thalassemia, sickle cell anemia and other hemoglobinopathies,"Technical and Biology, vol.3.pp.174-178.1986.